Travere Therapeutics TVTX
NASDAQ TVTX
$50.08 -2.35 (-4.48%)
At close: Oct 23, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Sale and Maturity of Investments (2013 - 2026)

Updated

Analysis

Travere Therapeutics (TVTX) Sale and Maturity of Investments (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Travere Therapeutics 4.72 Bn 4.32 Bn 167.41 Mn 36.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.37 Mn
Mar 31, 2026 48.78 Mn
Dec 31, 2025 82.42 Mn
Sep 30, 2025 106.62 Mn
Jun 30, 2025 81.40 Mn
Mar 31, 2025 53.16 Mn
Dec 31, 2024 55.05 Mn
Sep 30, 2024 54.32 Mn
Jun 30, 2024 105.60 Mn
Mar 31, 2024 111.36 Mn
Dec 31, 2023 50.00 Mn
Sep 30, 2023 87.70 Mn
Jun 30, 2023 102.75 Mn
Mar 31, 2023 94.12 Mn
Dec 31, 2022 52.38 Mn
Sep 30, 2022 112.29 Mn
Jun 30, 2022 152.61 Mn
Mar 31, 2022 64.72 Mn
Dec 31, 2021 57.51 Mn
Sep 30, 2021 134.04 Mn
API Access

Travere Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=TVTX&period=max&api_key=YOUR_API_KEY